ExploreWatchlistsPricing
  1. JP-listed companies
  2. KANEKA CORPORATION
  3. Financials
  4. Cash and cash equivalents

KANEKA CORPORATION (4118)

Market cap
¥352.3B
P/E ratio
10.2x
Kaneka develops advanced materials, medical devices, solar technology, and nutrition products across four business units serving infrastructure, housing, healthcare, and food industries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 202650,973+11.69%
Mar 31, 202545,639+3.80%
Mar 31, 202443,969+5.25%
Mar 31, 202341,774+0.09%
Mar 31, 202241,735-12.53%
Mar 31, 202147,716+23.14%
Mar 31, 202038,748-5.27%
Mar 31, 201940,905-14.15%
Mar 31, 201847,647+15.88%
Mar 31, 201741,116-5.37%
Mar 31, 201643,447+54.78%
Mar 31, 201528,070

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat